Skip to main content
SpringerLink
Log in

13-valent PCV vaccine may be more cost effective than 10-valent vaccines in the Philippines

  • Unknown
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Costs are reported in Philippine pesos.

Reference

  • Cost-Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Versus Lower-Valent Alternatives in Filipino Infants. Infectious Diseases and Therapy : 4 Sep 2021. Available from: URL: https://doi.org/10.1007/s40121-021-00538-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

13-valent PCV vaccine may be more cost effective than 10-valent vaccines in the Philippines. PharmacoEcon Outcomes News 889, 1 (2021). https://doi.org/10.1007/s40274-021-08089-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-08089-9

Search

Navigation